Breadcrumb
Drug Integrity
Drug and Device Recalls
|
AMCP supports the use of technologies to enhance communication of recall information to all relevant parties including patients who may have received such products.
|
Prescription Drug Importation
Policy 0302
02/01/2003 Introduced 02/01/2008 Revised 02/01/2013 Revised 02/21/2021 Revised |
Legislation or regulation that would permit the importation of prescription drugs presents potential patient safety issues. Allowing the importation of prescription drugs raises a challenge to ensure that quality assurance standards and supply chain integrity are maintained. There is scant evidence that importation will meaningfully impact the price of prescription drugs available to U.S. consumers, but ample evidence that it presents a clear threat to the security of our nation’s drug supply. AMCP will oppose legislation or regulation that would allow the importation of prescription drugs for sale in the United States until more conclusive data are available as to its likely impact.
(See also AMCP Where We Stand Position Statement – Prescription Drug Importation) |